Adebrelimab Combined With Bevacizumab and Docetaxel for Advanced Non-Squamous Non-small Cell Lung Cancer After Progression on First-line Immunotherapy
Clinical trial NCT06182800 · UNKNOWN
Trial details
- NCT number
- NCT06182800
- Sponsor
- The First Affiliated Hospital of Xinxiang Medical College
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-27
- Primary completion
- 2025-06-30
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.